Genomic & Biopharma NewsStudy seeks to understand genetic synergy in cleft palate
Like all of the individual elements of fetal development, palate growth is a marvel of nature. In part of this process, ledges of tissue on the sides of the face grow downwards on each side of the tongue, then upward, fusing at the midline at the top of the mouth.
|News Medical Life Sciences, 2017-07-19 11:34:39|
More than 100 million Americans have been diagnosed with diabetes or prediabetes, latest CDC report reveals
The new ‘National Diabetes Statistics Report’ released by the Centers for Disease Control and Prevention (CDC) on 18th July 2017, says that over 100 million adults in U.S. are presently living with prediabetes or diabetes.
|News Medical Life Sciences, 2017-07-19 11:19:04|
Researchers produce 'silk micrococoons' that could store sensitive molecular materials
Microscopic versions of the cocoons spun by silkworms have been manufactured by a team of researchers.
|News Medical Life Sciences, 2017-07-19 11:11:58|
Rise in life expectancy is grinding to a halt in England, says leading health advisor
The rise in life expectancy that has been seen in England for more than 100 years is now grinding to a halt, warns a former government and WHO advisor.
|News Medical Life Sciences, 2017-07-19 11:06:33|
Silk Road raises $47M to grow stroke-prevention business
Silk Road Medical has raised $47 million to commercialize its stroke-prevention devices in the U.S. and overseas. The funding positions Silk Road to build on approvals and reimbursement nods it has picked up on both sides of the Atlantic for its transcarotid artery revascularization devices.
|Fierce Biotech, 2017-07-19 10:29:30|
IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery
As open surgery has gradually been replaced by minimally-invasive and image-guided procedures, tissue adhesives are taking the place of sutures and surgical staples.
|News Medical Life Sciences, 2017-07-19 10:26:16|
EU nod for Gedeon’s novel antipsychotic Reagila
European regulators have approved Gedeon Richter’s novel antipsychotic Reagila as a new option for the treatment of patients with schizophrenia.
|PharmaTimes, 2017-07-19 10:23:19|
Genetic therapy for two inherited neurologic diseases moves closer to human clinical trials
Researchers at University of Massachusetts Medical School and Auburn University College of Veterinary Medicine are nearing human clinical trials on a genetic therapy for two rare neurological diseases that are fatal to children.
|News Medical Life Sciences, 2017-07-19 10:21:42|
Latinos left out of clinical trials … and possible cures
Two decades ago, Luis Antonio Cabrera received devastating news: He likely had only three months to live.
|News Medical Life Sciences, 2017-07-19 10:14:06|